Vitamin D3 for Life

Live Enlightened

Physiology

When Normal Blood Calcium Conceals a Skeletal Cost

Previous related pageVitamin D and Endocrine Coordination: Compensation and Failure: Full StudyNext related pageVitamin D and Endocrine Coordination: Compensation and Failure: Full Study
At a glance

Does normal blood calcium prove that bones are well supplied with mineral?

No. Blood calcium and mineral stored in bone are different measurements. In the mouse model discussed here, the body maintained blood calcium while bone mineralisation, the process of adding mineral to bone, deteriorated.

How could blood calcium stay normal while bone was affected?

After mice were genetically altered so their intestines could not respond normally to vitamin D, calcium absorption fell. Hormonal compensation increased calcium release from bone and reduced its incorporation into bone.

Does this mouse research diagnose a problem in someone with normal blood calcium?

No. It shows why one regulated blood result cannot describe the whole skeleton. The genetic experiments do not establish an individual’s bone health or a supplement dose.

Read the full article below ↓

A normal blood calcium result and a well-preserved skeleton are not interchangeable observations. In a targeted mouse experiment, endocrine compensation maintained circulating calcium while bone mineralisation deteriorated. A separate FGF23 experiment showed that correcting one abnormal mineral measurement did not restore the whole animal’s physiology.

A regulated blood concentration can hide a trade-off

Lieben and colleagues removed VDR from the mouse intestine, reducing vitamin-D-dependent calcium absorption while leaving signalling elsewhere intact. PTH and active vitamin D increased, and serum calcium remained comparable with controls under the principal study conditions.

The skeleton nevertheless accumulated less mineral and developed reduced cortical integrity. The researchers found evidence of both increased mineral release and reduced mineral incorporation. The preserved circulating concentration therefore reflected compensation, not absence of a disturbance.

This is a concrete example within Vitamin D and Homeostatic Balance. The model does not prove that every person with normal blood calcium has depleted skeletal stores. It demonstrates why one regulated concentration cannot, on its own, answer every question about tissue balance.

Maintaining one variable is not the same as protecting every tissue

The experiment showed local mineralisation changes involving osteoblast-lineage signalling and mineralisation inhibitors. A mineral-rich diet altered the phenotype, supporting the importance of supply. However, that diet changed calcium, phosphorus and lactose together, so it was not an isolated test of a simple human supplement intervention.

The hormone relationships in Vitamin D and Hormones help explain the study’s structure: intestinal supply and compensatory signals were considered together. The response was not a guarantee of whole-system safety. Nor did it show that all skeletal vitamin D receptor signalling is harmful.

Another model separated partial rescue from complete recovery

Shimada’s global Fgf23-knockout mice developed high phosphate and calcitriol, abnormal bone, poor growth and early mortality. Renal measurements supported increased phosphate reabsorption. The intervention disrupted a regulatory signal rather than simply lowering vitamin D status.

A low-phosphate diet improved serum phosphate and prolonged survival in some mice, but other abnormalities persisted. Correcting that measurement was therefore a partial rescue, not proof that the entire system had returned to normal. Global deletion and severe developmental illness also prevent attribution of every outcome to calcitriol alone.

The comparison belongs within Vitamin D and Endocrine Crosstalk because it concerns how signals and outcomes depend on each other. It does not establish that the two mouse models represent a single universal pathway or a common clinical diagnosis.

How to read the result without overextending it

The practical scientific question is which variable was preserved, which tissue changed and what the intervention actually altered. A normal result can be meaningful and still incomplete. An abnormal result can be corrected while other consequences remain unresolved.

Vitamin D and Endocrine Coordination: Compensation and Failure: Full Study develops the experimental details and wider endocrine comparisons. These studies support a bounded explanation of compensation and partial rescue, not a rule for interpreting an individual’s blood test or choosing a supplement dose.

Conclusion

In the selected models, endocrine compensation and whole-system recovery were different outcomes. Preserved blood calcium did not guarantee skeletal integrity, and lower phosphate did not correct every consequence of FGF23 loss. The lesson is to connect each measurement with its tissue and experimental context, rather than treating one marker as a complete account of health.

Primary source and publication details

Lieben L, Masuyama R, Torrekens S, Van Looveren R, Schrooten J, Baatsen P, Lafage-Proust MH, Dresselaers T, Feng JQ, Bonewald LF, Meyer MB, Pike JW, Bouillon R, Carmeliet G. Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D-induced inhibition of bone mineralization. The Journal of clinical investigation. 2012;122(5):1803-1815. DOI 10.1172/jci45890. PMID 22523068.

Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T, Fukumoto S, Tomizuka K, Yamashita T. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. The Journal of clinical investigation. 2004;113(4):561-568. DOI 10.1172/jci19081. PMID 14966565.

Related reading

Original sources

Source

Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D-induced inhibition of bone mineralization

Published in The Journal of clinical investigation (2012).

Publication details

Lieben L, Masuyama R, Torrekens S, Van Looveren R, Schrooten J, Baatsen P, Lafage-Proust MH, Dresselaers T, Feng JQ, Bonewald LF, Meyer MB, Pike JW, Bouillon R, Carmeliet G. Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D-induced inhibition of bone mineralization. The Journal of clinical investigation. 2012;122(5):1803-1815. DOI 10.1172/jci45890. PMID 22523068.

Read more →
Source

Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism

Published in The Journal of clinical investigation (2004).

Publication details

Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T, Fukumoto S, Tomizuka K, Yamashita T. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. The Journal of clinical investigation. 2004;113(4):561-568. DOI 10.1172/jci19081. PMID 14966565.

Read more →